We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
Cap. Flow
+$1.92B
Cap. Flow %
5.6%
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$200M
2
AMZN icon
Amazon
AMZN
+$126M
3
DB icon
Deutsche Bank
DB
+$109M
4
ISRG icon
Intuitive Surgical
ISRG
+$92.2M
5
WFC icon
Wells Fargo
WFC
+$83.3M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ABT icon
Abbott
ABT
+$79.1M
3
VFC icon
VF Corp
VFC
+$49M
4
JPM icon
JPMorgan Chase
JPM
+$48.5M
5
BNTX icon
BioNTech
BNTX
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 15.46%
3 Financials 11.88%
4 Communication Services 9.65%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
1201
Rigel Pharmaceuticals
RIGL
$778M
$219K ﹤0.01%
4,960
– –
ACIU icon
1202
AC Immune
ACIU
$232M
$217K ﹤0.01%
27,000
– –
NUAN
1203
DELISTED
Nuance Communications, Inc.
NUAN
$216K ﹤0.01%
+4,000
New +$211K
TVTX icon
1204
Travere Therapeutics
TVTX
$5.74B
$213K ﹤0.01%
14,500
– –
PSTX
1205
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$213K ﹤0.01%
22,000
– –
CVSA
1206
Covista Inc
CVSA
$4.38B
$211K ﹤0.01%
5,937
– –
TCRR
1207
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$211K ﹤0.01%
13,000
– –
KDMN
1208
DELISTED
Kadmon Holdings, Inc.
KDMN
$211K ﹤0.01%
55,000
– –
BIPC icon
1209
Brookfield Infrastructure
BIPC
$4.71B
$210K ﹤0.01%
+4,232
New +$204K
IDYA icon
1210
IDEAYA Biosciences
IDYA
$3.54B
$210K ﹤0.01%
10,000
– –
SGI
1211
Somnigroup International
SGI
$13.6B
$210K ﹤0.01%
+5,400
New +$207K
EQT icon
1212
EQT Corp
EQT
$33.8B
$208K ﹤0.01%
10,000
– –
ESPR
1213
DELISTED
Esperion Therapeutics
ESPR
$208K ﹤0.01%
10,000
– –
WB icon
1214
Weibo
WB
$1.96B
$207K ﹤0.01%
4,052
+526
+15% +$26.1K
MRO
1215
DELISTED
Marathon Oil Corporation
MRO
$207K ﹤0.01%
15,629
– –
BZUN
1216
Baozun
BZUN
$170M
$206K ﹤0.01%
5,638
+1,952
+53% +$68.8K
AMN icon
1217
AMN Healthcare
AMN
$1.42B
$205K ﹤0.01%
+2,200
New +$191K
HRI icon
1218
Herc Holdings
HRI
$5.68B
$204K ﹤0.01%
1,900
– –
CHAA.U
1219
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
$200K ﹤0.01%
+20,000
New +$200K
AERI
1220
DELISTED
Aerie Pharmaceuticals
AERI
$198K ﹤0.01%
12,100
– –
CNXC icon
1221
Concentrix
CNXC
$1.56B
$197K ﹤0.01%
+1,232
New +$190K
CUBE icon
1222
CubeSmart
CUBE
$9.23B
$196K ﹤0.01%
4,248
– –
STRO icon
1223
Sutro Biopharma
STRO
$423M
$196K ﹤0.01%
1,100
– –
XENE icon
1224
Xenon Pharmaceuticals
XENE
$6.21B
$196K ﹤0.01%
11,000
– –
CHNG
1225
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$196K ﹤0.01%
8,500
– –
47 48
49
50 51

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review

As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
  • DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
  • DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
  • DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.